Infudopa i.v.
2017-002488-17
Phase 1 small_molecule completed
Quick answer
Infudopa i.v. for Parkinson Disease is a Phase 1 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed